Category - GHP News

GHP News Latest Science

Moderna voluntarily withdraws BLA for Flu/COVID combination vaccine, plans resubmission later in 2025

On May 21, 2025, Moderna, announced a significant update regarding its flu/COVID combination vaccine candidate, mRNA-1083. In consultation with the U.S. Food and Drug Administration (FDA), Moderna has voluntarily...

27 May, 2025

2 min read

GHP News Latest Science

Novavax COVID-19 vaccine gains FDA approval for at-risk populations: Key details for clinicians and researchers

Novavax announced a significant regulatory milestone: the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for Nuvaxovid™, its recombinant protein-based, non-mRNA COVID-19...

27 May, 2025

3 min read

GHP News Latest Science

FDA, EMA and WHO guidance on updating COVID-19 vaccines for winter 2025/26

As the northern hemisphere prepares for the 2025/26 respiratory virus season, both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), as well as the World Health Organization (WHO)...

27 May, 2025

4 min read

GHP News Latest Science

The future of protein-based vaccines: Why mRNA is transforming the landscape, but all platforms remain essential

The rapid evolution of vaccine technology, driven by the unprecedented success of mRNA platforms during the COVID-19 pandemic, has fundamentally shifted our approach to protein-based vaccines. mRNA vaccines offer a...

27 May, 2025

4 min read

GHP News Latest Science

The WHO Pandemic Agreement:
A defining moment, if we seize it

On May 20, 2025, the World Health Assembly adopted the first-ever WHO Pandemic Agreement, a decision that many are hailing as a milestone for global health diplomacy. Framed as a response to the failures laid bare by...

22 May, 2025

5 min read

GHP News Latest Science

Revolutionizing immunization: MIT engineers develop microparticles for time-release vaccines

In a breakthrough that could transform global immunization strategies, engineers at the Massachusetts Institute of Technology (MIT) have developed biodegradable microparticles capable of delivering multiple vaccine...

16 May, 2025

4 min read

GHP News Latest Science

Oxford study reveals how COVID-19 vaccines reduce disease severity

A new study by researchers at the University of Oxford has shed light on how COVID-19 vaccines reduce the severity of illness, even when vaccinated people do get infected. The findings help explain why vaccinated...

13 May, 2025

3 min read

GHP News Latest Science

Singapore scientists launch SG-NEx, a landmark resource to advance precision medicine through long-read RNA sequencing

In a major milestone for biomedical science, researchers led by the Agency for Science, Technology and Research’s Genome Institute of Singapore (A*STAR GIS) have unveiled one of the world’s largest and most...

25 April, 2025

3 min read

GHP News Latest Science

Turning the tables on ticks: How scientists are unlocking immune responses to prevent Lyme disease

When a blacklegged tick (Ixodes scapularis) bites into human skin, it does more than simply take a blood meal. Through its saliva, the tick injects a complex cocktail of proteins designed to suppress the host’s immune...

23 April, 2025

4 min read

GHP News Latest Science

Vaccination significantly reduces long COVID risk in youth, new study confirms

A groundbreaking study led by the Perelman School of Medicine at the University of Pennsylvania reveals that unvaccinated children and adolescents were up to 20 times more likely to develop long COVID than their...

22 April, 2025

4 min read